Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mishra, Dhruva K ^a   Wu, Yanyuan ^a,b   Sarkissyan, Marianna ^a   Sarkissyan, Suren ^a   Chen, Zujian ^a   Shang, Xiying ^a   Ong, May ^a   Heber, David ^b   Koeffler, H Phillip ^b,c   Vadgama, Jaydutt V ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AFRICAN AMERICAN; APAL GENE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BSML GENE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOK1 GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; ONCOGENE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RACE DIFFERENCE; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TAQL GENE; VITAMIN D RECEPTOR GENE;

ADULT; AFRICAN AMERICANS; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; SURVIVAL RATE; VITAMIN D;

EID: 84874884825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057967     Document Type: Article

References (38)

1. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, (2012) Alterations in Vitamin D signaling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10: 483 doi:10.1186/1471-2407-10-483.
2. Engel LS, Orlow I, Sima CS, Satagopan JM, Mujumdar UJ, et al. (2012) Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: A nested case-control study. Cancer Epidemiol Biomarkers Prev 21 (10):: 1856-67 PMID:22892281.
3. Marik R, Fackler M, Gabrielson E, Zeiger MA, Sukumar S, et al. (2010) DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther 10 (1):: 44-53 PMID: 20431345.
4. Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ, (2006) Epigenetic corruption of VDR signaling in malignancy. Anticancer Res 26 (4A):: 2557-66 PMID: 16886664.
5. Banwell CM, O'Neill LP, Uskokovic MR, Campbell MJ, (2004) Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. J Steroid Biochem Mol Biol 90: 245-249 PMID: 15225779.
6. Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, et al. (2004) Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 13: 1633-9 PMID: 15175274.
7. Alimirah F, Peng X, Murillo G, Mehta RG, (2011) Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One 6 (1):: e16024 PMID: 21283672.
8. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, et al. (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14: 401-20 PMID: 10707958.
9. Raimondi S, Johansson H, Maisonneuve P, Gandini S, (2009) Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30: 1170-1180 PMID: 19403841.
10. Tang C, Chen N, Wu M, Yuan H, Du Y, (2009) FokI polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 117: 391-399 doi:10.1007/s10549-008-0262-4 PMID: 19145484.
11. Mishra DK, Bid HK, Srivastava DS, Mandhani A, Mittal RD, (2005) Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India. Urol Int 74: 315-8 PMID:15897695.
12. Xu Y, Shibata A, Mcneal JE, Stamey TA, Feldman D, et al. (2003) Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol Biomark Prev 12: 23-7 PMID:12540499.
13. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP, (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338 (2):: 143-56 PMID:15315818.
14. Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, et al. (2000) Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control 11: 25-30 PMID:10680726.
15. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, et al. (2007) Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 9: R9 (doi:10.1186/bcr1642).
16. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, et al. (1999) Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 83: 723-6 PMID:10597185.
17. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, et al. (2004) Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 10: 5472-81 PMID:15328186.
18. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, et al. (2012) Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res 14 (2):: R58 PMID:22480149.
19. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB, et al. (2012) Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat 132 (2):: 683-91 PMID:22130867.
20. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N, (2003) Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 35: 550-5 PMID:14749534.
21. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, et al. (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case control study of Caucasian and African-American women. Breast Cancer Res 9: R84 PMID:18067661.
22. Rodriquez S, Gaunt TR, Day INM (2012) Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies. Available: http://www.oege.org/software/hwe-mr-calc.html. Accessed 2012 Jun 30.
23. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2):: 263-5 PMID:15297300.
24. Broad Institute Website. Available: http://www.broad.mit.edu/mpg/haploview. Accessed 2012 Sep 15.
25. McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, et al. (2009) Vitamin D receptor polymorphisms and breast cancer risk: results from the national cancer institute breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 18: 297-305 PMID:19124512.
26. Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, et al. (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 10: R31 PMID:18419802.
27. Dunning AM, McBride S, Gregory J, (1999) No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20: 2131-5 PMID:10545416.
28. Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, et al. (2001) Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 85: 171-5 PMID:11461072.
29. Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, et al. (2004) Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibrodenoma risk in Caucasian women. Cancer 101: 264-9 PMID:15241822.
30. Chen WY, Bertone-Juhnson ER, Hunter DJ, Willett WC, Hankinson SE, (2005) Associations between polymorphisms in the Vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2335-9 PMID:16214913.
31. VandeVord PJ, Wooley PH, Darga LL, Severson RK, Wu Bin, et al. (2006) Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 100: 103-7 PMID:16791482.
32. John EM, Schwartz GG, Koo J, Wang W, Ingles SA, (2007) Sun exposure, Vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. American J Epidemiology 166: 1409-19 PMID:17934201.
33. Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, et al. (2009) Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat 115: 629-33 PMID:18587672.
34. Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C, et al. (2008) Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocrine-Related Cancer 15: 975-983 PMID:18719092.
35. Barroso E, Fernandez LP, Milne RL, Pita G, Sendagorta E, et al. (2008) Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer 8: 385 doi:10.1186/1471-2407-8-385. PMID:19105801.
36. Mohr SB, Gorham ED, Alcaraz JE, Kane CI, Macera CA, et al. (2012) Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinol 4 (2):: 152-7 PMID: 22928071.
37. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, et al. (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100: 1581-1591 PMID: 19001601.
38. Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, et al. (2011) Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. Oncologist 16 (9):: 1215-27 Epub 2011 Aug 11. PMID: 21835895.